About Gilead Sciences

Gilead Sciences is a global biopharmaceutical company with over 17,000 employees focused on discovering, developing, and delivering innovative medicines for people with serious diseases. For nearly four decades, Gilead has contributed to advances in HIV treatment and prevention and continues to expand research across oncology, liver disease, and inflammatory conditions. Our work spans the full lifecycle of medicine development, including scientific research, clinical trials, manufacturing, and global commercialization. Teams across research, clinical development, manufacturing, and corporate functions collaborate to translate scientific discovery into therapies that reach patients worldwide. Gilead operates in more than 35 countries and partners with healthcare providers, research institutions, and global organizations to improve access to medicines and support public health initiatives. Through Kite Pharma, Gilead also advances cell therapy research, including CAR-T therapies designed to treat certain cancers. Kite’s work represents a key component of Gilead’s oncology strategy and investment in next-generation therapeutic approaches.